ProKidney
The development of a cell therapy candidate that has the potential to improve the lives of patients with chronic kidney disease. Learn more
Launch date
Employees
Market cap
AUD464m
Enterprise valuation
(AUD193m) (Public information from Sep 2024)
Share price
$2.39 PROK
Winston-Salem North Carolina (HQ & founding location)
Authorizing premium user...